U.S. Autodesk, McKesson, MicroStrategy
May 29 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Autodesk, McKesson and Microstrategy, on Wednesday.
HIGHLIGHTS
* Analog Devices Inc ADI.O: Raymond James raises target price to $260 from $215 |
* Autodesk Inc ADSK.O: Baird cuts target price to $289 from $296 |
* Cencora Inc COR.N: Baird raises target price to $280 from $277 |
* McKesson Corp MCK.N: Baird raises target price to $679 from $671 |
* MicroStrategy Inc MSTR.O: Canaccord Genuity raises target price to $2,047 from $1,590 |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Agios Pharmaceuticals Inc AGIO.O: Leerink Partners raises target price to $59 from $49 |
* Akoustis Technologies Inc AKTS.O: Craig-Hallum cuts target price to $0.25 |
* Akoustis Technologies Inc AKTS.O: Craig-Hallum cuts to hold rating |
* Albany International AIN.N: BofA Global Research cuts price objective to $90 from $95 |
* American Airlines AAL.O: Bernstein cuts target price to $18 from $22 |
* American Airlines AAL.O: BofA Global Research cuts price objective to $11 from $12 |
* American Airlines AAL.O: Jefferies cuts target price to $12 from $17 |
* American Airlines AAL.O: Jefferies cuts to hold from buy |
* American Airlines AAL.O: Seaport Research Partners cuts to neutral from buy |
* American Airlines AAL.O: TD Cowen cuts target price to $16 from $18 |
* American Homes 4 Rent AMH.N: Barclays cuts target price to $42 from $43 |
* Analog Devices Inc ADI.O: Raymond James raises target price to $260 from $215 |
* Atmus Filtration Technologies Inc ATMU.N: Northland Capital raises PT to $36 from $34 |
* Atyr pharma Inc LIFE.O: Jonestrading assumes coverage with buy rating; target price $22 |
* Autodesk Inc ADSK.O: Baird cuts target price to $289 from $296 |
* Autodesk Inc ADSK.O: Citigroup cuts target price to $286 from $298 |
* Bank Ozk OZK.O: Citigroup cuts target price to $37 from $57 |
* Bank Ozk OZK.O: Citigroup cuts to sell from buy |
* Booz Allen Hamilton BAH.N: Barclays raises target price to $153 from $135 |
* Booz Allen Hamilton Holding Corp BAH.N: Jefferies raises target price to $185 from $180 |
* Box Inc BOX.N: Morgan Stanley cuts target price to $30 from $32 |
* Box Inc BOX.N: UBS cuts target price to $31 from $34 |
* Braze Inc BRZE.O: Oppenheimer cuts target price to $60 from $75 |
* Cardinal Health Inc CAH.N: Baird raises target price to $129 from $128 |
* Caretrust REIT Inc CTRE.N: Raymond James raises target price to $29 from $27 |
* Caretrust REIT Inc CTRE.N: Wedbush initiates coverage with neutral rating; PT $26 |
* Carnival Corp CCL.N: Truist Securities cuts target price to $17 from $18 |
* Caseys General Stores Inc CASY.O: JP Morgan cuts target price to $298 from $299 |
* Cava Group Inc CAVA.N: Jefferies raises target price to $94 from $72 |
* Cava Group Inc CAVA.N: JP Morgan raises target price to $77 from $64 |
* Cava Group Inc CAVA.N: Morgan Stanley raises target price to $85 from $68 |
* Cava Group Inc CAVA.N: Morgan Stanley raises target price to $85.00 from $68.00 |
* Cava Group Inc CAVA.N: TD Cowen raises target price to $90 from $73 |
* Cava Group Inc CAVA.N: Wedbush raises target price to $90 from $74 |
* Cencora Inc COR.N: Baird raises target price to $280 from $277 |
* Cervomed Inc CRVO.O: Jonestrading initiates coverage with buy rating; target price $70 |
* Chipotle Mexican Grill Inc CMG.N: Truist Securities raises target to $3520 from $3440 |
* Cognition Therapeutics Inc CGTX.O: H.C. Wainwright initiates coverage with buy rating |
* Cognition Therapeutics Inc CGTX.O: H.C. Wainwright initiates coverage with PT $10 |
* Constellation Brands STZ.N: Barclays cuts target price to $288 from $295 |
* Core Scientific Inc CORZ.O: BTIG raises to buy from neutral |
* Crane Co CR.N: BofA Global Research raises price objective to $165 from $140 |
* Crowdstrike Holdings Inc CRWD.O: JP Morgan raises target price to $400 from $371 |
* CubeSmart CUBE.N: BMO cuts to market perform from outperform; cuts PT to $47 from $50 |
* Cytokinetics Inc CYTK.O: Truist Securities cuts target price to $70 from $86 |
* Dell Technologies Inc DELL.N: BofA Global Research ups price objective to $180 from $130 |
* Delta Air Lines Inc DAL.N: Citigroup raises target price to $65.00 from $55.00 |
* Digital Turbine Inc APPS.O: Craig-Hallum cuts target price to $5 from $10 |
* Domo Inc DOMO.O: TD Cowen cuts target price to $8 from $10 |
* Draftkings Inc DKNG.O: Stifel cuts target price to $50 from $51 |
* Duckhorn Portfolio Inc NAPA.N: RBC cuts target price to $11 from $14 |
* Dupont DD.N: UBS raises target price to $98 from $93 |
* Dycom Industries Inc DY.N: BofA Global Research raises price objective to $198 from $160 |
* Elf Beauty Inc ELF.N: Truist Securities raises target price to $210 from $200 |
* First Solar Inc FSLR.O: RBC raises target price to $315 from $195 |
* First Solar Inc FSLR.O: UBS raises target price to $350 from $270 |
* Five Below Inc FIVE.O: Citigroup cuts target price to $185 from $210 |
* Fortrea Holdings Inc FTRE.O: TD Cowen initiates coverage with hold rating; PT $27 |
* Globus Medical Inc GMED.N: BTIG raises target price to $72 from $63 |
* GoDaddy Inc GDDY.N: JP Morgan raises target price to $175 from $136 |
* Heico Corp HEI.N: Vertical Research raises target price to $245 from $226 |
* Hireright Holdings Corp HRT.N: Jefferies raises target price to $14 from $11 |
* HNI Corp HNI.N: Benchmark raises target price to $57 from $54 |
* Ikena Oncology Inc IKNA.O: Wedbush cuts target price to $2 from $8 |
* Ikena Oncology Inc IKNA.O: Wedbush cuts to neutral from outperform |
* Ikena Oncology Inc IKNA.O: H.C. Wainwright cuts target price to $4 from $11 |
* Independent Bank Group Inc IBTX.O: Truist Securities cuts to hold from buy |
* Independent Bank Group Inc IBTX.O: Truist Securities raises target to $50 from $46 |
* Insmed Inc INSM.O: Barclays raises target price to $63 from $40 |
* Insmed Inc INSM.O: BofA Global Research raises price objective to $62 from $40 |
* Insmed Inc INSM.O: H.C. Wainwright raises target price to $70 from $52 |
* Insmed Inc INSM.O: JP Morgan raises target price to $55 from $36 |
* Insmed Inc INSM.O: TD Cowen raises target price to $67 from $45 |
* Insmed Inc INSM.O: Truist Securities raises target price to $68 from $48 |
* Insmed Inc INSM.O: UBS raises target price to $58 from $46 |
* Insmed Inc INSM.O: Wells Fargo raises target price to $77 from $55 |
* Invitation Homes INVH.N: Barclays cuts target price to $40 from $41 |
* JetBlue Airways Corp JBLU.O: Citigroup cuts target price to $6.50 from $6.90 |
* Liberty Energy Inc LBRT.N: Citigroup raises target price to $32 from $24 |
* Liberty Energy Inc LBRT.N: Citigroup raises to buy from neutral |
* Live Nation Entertainment Inc LYV.N: JP Morgan cuts target price to $116 from $126 |
* LSB Industries Inc LXU.N: Deutsche Bank raises target price to $11 from $9 |
* McKesson Corp MCK.N: Baird raises target price to $679 from $671 |
* Medpace Holdings Inc MEDP.O: TD Cowen initiates with buy rating; target price $452 |
* MicroStrategy Inc MSTR.O: Canaccord Genuity raises target price to $2,047 from $1,590 |
* Mind Medicine (Mindmed) Inc MNMD.O: Baird initiates with outperform rating; PT $27 |
* Molson Coors Beverage Company TAP.N: Barclays cuts target price to $55 from $62 |
* Mongodb Inc MDB.O: Citigroup cuts target price to $480 from $500 |
* Monro Inc MNRO.O: Jefferies cuts target price to $25 from $28 |
* MYR Group Inc MYRG.O: Baird cuts target price to $170 from $180 |
* Nexpoint Residential Trust Inc NXRT.N: Truist Securities cuts target to $34 from $35 |
* Norwegian Cruise Line Holdings Ltd NCLH.N: Truist Securities raises PT to $21 from $20 |
* Norwegian Cruise Line Holdings Ltd NCLH.N: Truist Securities raises to buy from hold |
* Palomar Holdings Inc PLMR.O: Evercore ISI raises target price to $89 from $88 |
* Palomar Holdings Inc PLMR.O: Jefferies raises target price to $98 from $95 |
* Palomar Holdings Inc PLMR.O: KBW raises target price to $96 from $93 |
* Palomar Holdings Inc PLMR.O: Truist Securities raises target price to $100 from $97 |
* PDF Solutions Inc PDFS.O: D.A. Davidson raises target price to $42 from $40 |
* Phillips Edison & Co Inc PECO.O: Deutsche Bank cuts target price to $38 from $41 |
* RBC Bearings Inc RBC.N: William Blair resumes coverage with outperform rating |
* Resources Connection Inc RGP.O: Noble Capital initiates coverage with outperform rating |
* Resources Connection Inc RGP.O: Noble Capital initiates coverage with target price $15 |
* RLJ Lodging Trust RLJ.N: Baird cuts target price to $13 from $14 |
* Royal Caribbean Group RCL.N: Truist Securities raises target price to $175 from $151 |
* Rush Street Interactive Inc RSI.N: Craig-Hallum raises target price to $11 from $10 |
* Sage Therapeutics Inc SAGE.O: Baird initiates coverage with neutral rating and $15 PT |
* Skyline Champion Corp. SKY.N: Barclays cuts target price to $68 from $76 |
* Surmodics Inc SRDX.O: Needham cuts to hold from buy |
* Telephone and Data Systems Inc TDS.N: JP Morgan cuts target price to $34 from $36 |
* TKO Group TKO.N: JP Morgan raises target price to $126 from $103 |
* TransDigm Group TDG.N: BofA Global Research raises price objective to $1,460 from $1,310 |
* Triumph Group Inc TGI.N: Barclays cuts target price to $18 from $20 |
* Triumph Group Inc TGI.N: TD Cowen cuts target price to $14 from $19.5 |
* Triumph Group Inc TGI.N: TD Cowen cuts to hold from buy |
* Uipath Inc PATH.N: Scotiabank cuts target price to $25 from $30 |
* United Airlines UAL.O: Citigroup raises target price to $96 from $80 |
* United Airlines UAL.O: Jefferies raises target price to $65 from $54 |
* United Airlines UAL.O: Jefferies raises to buy from hold |
* United States Cellular Corp USM.N: JP Morgan raises target price to $69 from $51 |
* Veeva Systems Inc VEEV.N: Citigroup raises target price to $274 from $268 |
* Verastem Inc VSTM.O: Alliance Global Partners cuts target price to $20 from $34 |
* Xenia Hotels & Resorts Inc XHR.N: Baird raises target price to $16 from $14 |
* Zscaler Inc ZS.O: BMO cuts target price to $192 from $255 |
* Zscaler Inc ZS.O: UBS cuts target price to $270 from $300 |
(Compiled by Bengaluru Newsroom)
</body></html>Похожие активы
Последние новости
Правовая оговорка: Компании группы XM Group предоставляют только услуги по исполнению сделок и доступ к нашей торговой онлайн-среде, в которой пользователи могут просматривать и (или) пользоваться материалами, доступными на вебсайте либо доступными по ссылкам с данного сайта на другие. Предоставление доступа к онлайн-среде не меняет сути предоставляемых услуг и не расширяет их. Такой доступ и пользование материалами предоставляются с учетом:(i) «Условий и положений»; (ii) «Предупреждений о рисках» и (iii) полного текста «Правовой оговорки». Следовательно, подобные материалы предоставляются лишь в качестве информации общего характера. В частности, просим Вас иметь в виду, что материалы, содержащиеся в нашей торговой онлайн-среде, не являются ни просьбой осуществить какие-либо транзакции на финансовых рынках, ни предложением к осуществлению подобных транзакций. Торговля на любом финансовом рынке подразумевает большой риск потери Вашего капитала.
Все материалы, опубликованные в нашей торговой среде, предоставляются только в образовательных или информационных целях и не содержат (и не должны рассматриваться как содержащие) финансовых, инвестиционных или торговых рекомендаций, а также информации о стоимости наших услуг по предоставлению доступа к рынкам, либо предложения или содействия в проведении транзакций по какому-либо финансовому инструменту или по незапрашиваемым финансовым услугам по отношению к Вам.
Любые материалы на данном вебсайте, созданные третьими лицами, а также материалы, подготовленные XM, такие как мнения экспертов, новости, исследования, анализ, котировки и другая информация, а также ссылки на сторонние сайты предоставляются в виде «как есть», как рыночная информация общего характера, и не являют собой рекомендации по инвестициям. Принимая во внимание то, что любые материалы рассматриваются как инвестиционное исследование, Вам следует учесть и принять тот факт, что никакие материалы не подготавливались и не предназначались к использованию в соответствии с правовыми нормами, способствующими независимости инвестиционных исследований. Следовательно, материалы следует рассматривать как материалы рекламного характера согласно соответствующим законам и правовым нормам. Рекомендуем Вам прочесть и уяснить для себя положения наших «Уведомления о субъективном инвестиционном исследовании» и «Предупреждения о рисках» в отношении приведённой выше информации. С этими документами можно ознакомиться здесь.
